We, Zhongshan Sansure Hygene Biomedicine Co., Ltd.. was founded in 2004, located in Zhongshan Torch Development Zone, is a leading genetic engineering biopharmaceutical enterprise with independent intellectual property rights in China.

Sansure Hygene was staffed with a creative team. The factory was equipped with first-class facilities and compliant with the guideline of current China GMP.

Sansure Hygene’s main product is Recombinant Human Growth Hormone for Injection (Somatropin, rhGH), approved by CFDA in 2005.